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AbStRACt
Polymorphous low-grade adenocarcinoma (PLGA) is difficult to diagnose both clinically and histologically due to its 
indolent presentation, and because of its morphological diversity that includes several microscopic patterns. The aggres-
sive biologic behavior seen in minor salivary glands as compared to major glands is apparently associated histologically 
to a predominance of the papillary pattern in the former. Biologic behavior of PLGA in the major salivary glands is 
uncertain, as some cases have developed recurrences and metastases independently of the presence of a papillary pattern. 
A case of PLGA originated de novo in parotid gland is presented a 60 year-old male, treatment was surgically excised 
through superficial parotidectomy and to postoperative radiotherapy (46 Gy). Forty-eight months later the patient is 
alive with no signs of recurrence, as well as a review of the literature, with particular emphasis in its differential diagnosis 
and biological behavior.
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IntRoduCtIon
Polymorphous low-grade adenocarcinoma (PLGA) was 
first described simultaneously in 1983 by two groups of re-
searchers under different names. Batsakis et al denominated 
it as terminal duct carcinoma and Freedman et al named 
it as lobular carcinoma. At present, this neoplasm is well 
recognized and known as PLGA (1-3).
PLGA is the second most frequently diagnosed malignant 
neoplasm of the minor salivary glands, with approximately 
60% of the cases located in the palate. Age at diagnosis ran-
ges from 16 to 94 years, with a mean of 59 years and a 2:1 
female predilection (4).  Evolution varies from some months 
to several years and the lesion is usually asymptomatic (5). 
Surgery is the treatment of choice and survival is in most 
cases long, as recurrences have been reported between 9% 
and 17% and regional metastases have been found between 
9% and 15 % of the cases (4). Most deaths associated to this 
neoplasm are related to invasion to vital structures (6).
Although PLGA occurs predominantly in the minor salivary 
glands, there are reports in the world literature which shows 
that at least 32 cases have occurred in the parotid gland, 
either arising de novo or as neoplasms developing in a pre-
existent pleomorphic adenoma (carcinoma ex pleomorphic 
adenoma) (3,5,6-13). In this article we report a case of 
PLGA that developed de novo in the parotid gland and was 
surgically treated with facial nerve preservation. 
CASe RePoRt
A 60 year-old male had an asymptomatic right pre-auricular 
painless mass, which had gradually increased in size over a 
period of seven years. Axial CT showed a 5 x 5 cm multi-
cystic tumoral mass that did not involve the parapharyngeal 
space (Figure 1). Aspiration biopsy rendered a diagnosis of 
pleomorphic adenoma (PA) and the lesion was surgically 
excised through superficial parotidectomy with facial nerve 
preservation.  
Macroscopically the lesion was well circumscribed, partly 
encapsulated and measured 5 x 4 x 4 cm and comprised 
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Fig. 1. CT Scan. This image shows a multicystic 
tumoral mass that do not involve the parapharyn-
geal space.
Fig. 2.  a) PLGA solid pattern areas with tubular focus H&E lower power, 
b) solid pattern areas with tubular focus, H&E high power, c) showing 
individual cell infiltration Indian file, high power H&E. 
around 90% of the specimen. The cut surface had yellow-
brown solid areas intermingled with cystic spaces.
Microscopically the lesion was composed by round to oval 
isomorphic cells with bland, minimally hyperchromatic oval 
nuclei, occasional nucleoli and scant mitotic figures. These 
cells formed diverse patterns, including lobular, papillary 
and follicular, with predominance of the first two types. The 
neoplasm infiltrated the adjacent adipose and subcutaneous 
tissues. The cystic spaces were lined by squamous epithelium 
with focal production of keratin. In other areas there were 
scant and isolated cells were scattered in hyalinized material 
that resembled basal lamina. Neither perineural invasion 
nor vascular permeation were seen in the studied sections 
(Figures 2,3). 
Immunohistochemical analysis revealed an intensely posi-
tive reaction to cytokeratin.  Actin and S-100 protein were 
focally positive, while glial fibrillary acidic protein was 
negative in all neoplastic cells. 
Histopathologic diagnosis was PLGA and the patient was 
submitted to postoperative radiotherapy (46 Gy). Forty-
eight months later the patient is alive with no signs of 
recurrence.
dISCuSSIon
PLGA develops from the intercalated (terminal) duct cells, 
and it is characterized by its cytologic uniformity with 
histomorphologic diversity, infiltrative growth and low 
metastatic potential (3-18).
This tumor shows a marked predominance for minor sa-
livary glands, although some cases have been identified in 
the parotid gland, where most cases have been diagnosed as 
part of a carcinoma ex pleomorphic adenoma, such as those 
in the series reported by Kemp et al, who found that only 
two out of twenty cases arose de novo, and the rest showed 
remnants of pleomorphic adenoma (3-12).
It is interesting to note that possible differences with respect 
to the biologic behavior among those cases that arise de 
novo and those that develop from a pleomorphic adenoma 
have not been mentioned in the literature. This may be due 
to the relatively few cases of this neoplasm and the lack of 
a long follow-up of the affected patients.
Treatment in all cases, independently of its location consists 
of complete surgical excision, and neck dissection should 
be added only in those cases with cervical lymphadenopa-
thy. Two points to take into consideration to decide giving 
post-operative radio or chemotherapy are the presence of 
perineural invasion and vascular permeation of tumoral 
cells (6).
Only 9% to 17% of all PLGA that develop from the minor 
salivary glands show local recurrence and regional metas-
tases have revealed regional metastases. Distant metastases 
have seldom been reported (4). Recurrence has been estima-
ted in 33% for parotid tumors, while lymph node metastases 
have been found in 6.6%, with no cases reported to date with 
distant metastases (5,16).
At present, several studies suggest that minor salivary gland 
PLGAs with a predominant papillary and papillary-cystic 
configuration are more aggressive, as these show a higher 
incidence of cervical lymph node metastases (7).
However, although the papillary pattern have been found 
in most of the reported cases of PLGA located in the pa-
rotid (Table 1), there has been only one case with lymph 
node metastasis (13). As PLGAs of major salivary glands 
are very infrequently diagnosed, it is difficult to determine 
the particular biologic behavior of  this neoplasm in the 
parotid gland.
 On the other hand, Mark et al mentioned that some diffe-
rences do exist in PLGA located in the minor salivary glands 
with respect to those cases located in the parotid gland (7-8). 
These chromosomic differences do not imply differences in 
biologic behavior due to its anatomical location, but they 
support the possible origin of PLGA of the parotid gland 
in a PA (7-8).
This entity is difficult to diagnose because of the multiple 
histomorphologic patterns it may present and its cytologic 
uniformity. These features are similar to those seen  in PA 
and in adenoid cystic carcinoma. Immunohistochemical 
studies that compares PA and PLGA have shown that glial 
fibrillary acidic protein (GFAP) is negative in PLGA and 
positive in PA (5,16). 
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In the present case GFAP was negative in all histomorpho-
logic patterns, which supports the diagnosis of PLGA. The 
morphologic pattern, immunohistochemical findings and 
clinical evolution suggest that this is a PLGA that arose de 
novo in the parotid gland.
It is necessary to consider that PLGA may occur in the major 
salivary glands de novo or as a part of a PA that does not 
shows clinical evidence of malignancy, as the clinical course 
of the PLGA is usually indolent and may mimic a benign 
neoplasm, therefore making necessary to examine carefully 
the entire surgical specimen. In case a PLGA is recognized, 
it is important to inform the predominant histologic pat-
tern, the occurrence of perineural invasion and vascular 
permeation, in order to determine if  these criteria may be 
of assistance to identify its biological behavior.
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28 69/F 4cm No No 24 months Yes Puxeddu,et al 4 














Yes Nagao, et al 
12 
32 60 / M 5 cm. No No 36 months Yes Ruíz-Godoy, et al. 
 
table 1. Reported cases of PLGA of the parotid gland.
* Series of 22 cases; 15 of which had follow-up.
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